Baltimore, United States
NextStep Robotics, founded in 2017, operates at the intersection of AI, Biotechnology, and Robotics in the United States. The company has developed the AMBLE, a clinically proven robotic device aimed at aiding gait training and reversing foot drop, a condition affecting approximately 30% of the 800,000 new stroke cases in the U.S. annually.
The traditional approach to treating foot drop has relied heavily on rigid braces and "crutches," methods that have not evolved significantly over the years. NextStep Robotics offers a groundbreaking alternative: a low-cost, portable ankle robot that could revolutionize treatment. In a pilot study, 85% of participants reduced dependence on conventional assistive devices, highlighting the potential efficacy of this solution.
The company's innovative approach and promising pilot results have attracted a $400,000 Venture Round investment as of January 10, 2024, positioning NextStep Robotics as a significant player in rehabilitation technology.
